Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Genoptix, Inc.
January 29 2011 - 10:01AM
Business Wire
Bull & Lifshitz, LLP announces an investigation into
possible breaches of fiduciary duty in connection with the proposed
acquisition of Genoptix, Inc. (NASDAQ: GXDX - News) (referred to as
"Genoptix" or the “Company”) by Novartis Finance Corporation
(“Novartis”) in a cash transaction valued at approximately $470
million and an enterprise value of $330 million.
Under the terms of the merger agreement, Novartis will commence
an all cash tender offer for all outstanding shares of common stock
of Genoptix at $25.00 per share.
Bull & Lifshitz, LLP's investigation is focused on whether
the proposed deal provides adequate value to the Company’s
shareholders. If you are a holder of Genoptix stock and want to
discuss your legal rights, you may e-mail or call Bull &
Lifshitz, LLP who will, without obligation or cost to you, attempt
to answer your questions.
If you are a shareholder of Genoptix and would like more
information about our investigation, please contact Joshua M.
Lifshitz, Esq. by telephone at (866) 313-6222 or by sending an
e-mail including your contact information to:
counsel@nyclasslaw.com. All e-mail correspondence should make
reference to Genoptix.
Bull & Lifshitz, LLP is a New York City-based law firm with
significant experience representing investors in merger-related
shareholder class actions, shareholder derivative actions, and
securities fraud class actions. For more information about the
firm, please visit our website at www.nyclasslaw.com.
ATTORNEY ADVERTISING. © 2011 Bull & Lifshitz, LLP.
The law firm responsible for this advertisement is Bull &
Lifshitz, LLP, 18 East 41st Street, New York, New York 10017, (212)
213-6222. Prior results do not guarantee or predict a similar
outcome with respect to any future matter.
Genoptix, Inc. (MM) (NASDAQ:GXDX)
Historical Stock Chart
From May 2024 to Jun 2024
Genoptix, Inc. (MM) (NASDAQ:GXDX)
Historical Stock Chart
From Jun 2023 to Jun 2024